Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Church & Dwight (CHD) Meets Q2 Earnings Estimates
Church & Dwight (CHD) Meets Q2 Earnings Estimates

Church & Dwight (CHD) came out with quarterly earnings of $0.89 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.94 per share a year ago. These figures are

LyondellBasell (LYB) Q2 Earnings and Revenues Surpass Estimates
LyondellBasell (LYB) Q2 Earnings and Revenues Surpass Estimates

LyondellBasell (LYB) came out with quarterly earnings of $4.3 per share, beating the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $0.62 per share a year ago. These

3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

The easiest way to judge

3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio

It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.

The

Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?
Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

The easiest, most

Apple Falls Post Q3 on Supply Chain Woes: Buy the Dip in ETFs?
Apple Falls Post Q3 on Supply Chain Woes: Buy the Dip in ETFs?

On July 30, Apple AAPL came out with fiscal Q3 earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.88 per share as well as the year-ago level of $1.57 per share. The company's

Marcus Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Hotel, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d14bb504-852b-4d13-a69a-8cec9d4eb799.png
Marcus Q2 Earnings Call Highlights

Key Points

Madison Air Solutions Q2 Earnings Call Highlights
Madison Air Solutions Q2 Earnings Call Highlights

Key Points

Mid-America Apartment Communities Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Mid-America Apartment Communities Q2 Earnings Call Highlights

Key Points

Mastercard Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Mastercard Q2 Earnings Call Highlights

Key Points

Live Nation Entertainment Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Mobile phone network, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/828b91fb-678a-4621-906b-21e972059e7d.png
Live Nation Entertainment Q2 Earnings Call Highlights

Key Points

Lsb Industries Q2 Earnings Call Highlights
Lsb Industries Q2 Earnings Call Highlights

Key Points

Life Time Group Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
Life Time Group Q2 Earnings Call Highlights

Key Points

Bancorp Q2 Earnings Call Highlights
Bancorp Q2 Earnings Call Highlights

Key Points

Newell Brands Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Aerospace components, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/3938f51e-9b01-45a9-aed1-ff9d047063fc.png
Newell Brands Q2 Earnings Call Highlights

Key Points

GCL Global Q4 Earnings Call Highlights
GCL Global Q4 Earnings Call Highlights

Key Points

Wall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High?
Wall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High?

Shares of MoonLake Immunotherapeutics (MLTX) have gained 0.2% over the past four weeks to close the last trading session at $18.99, but there could still be a solid upside left in the stock if

Wall Street Analysts See a 58.42% Upside in Prelude Therapeutics (PRLD): Can the Stock Really Move This High?
Wall Street Analysts See a 58.42% Upside in Prelude Therapeutics (PRLD): Can the Stock Really Move This High?

Prelude Therapeutics Incorporated (PRLD) closed the last trading session at $5.05, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Can Aehr Test Systems (AEHR) Climb 49.6% to Reach the Level Wall Street Analysts Expect?
Can Aehr Test Systems (AEHR) Climb 49.6% to Reach the Level Wall Street Analysts Expect?

Shares of Aehr Test Systems (AEHR) have gained 9.9% over the past four weeks to close the last trading session at $76.87, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?
Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?

Definium Therapeutics, Inc. (DFTX) closed the last trading session at $44.49, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets